Acceder

Bibliografías temáticas / Tolérance des lymphocytes T / Artículos de revistas

Artículos de revistas sobre el tema "Tolérance des lymphocytes T"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Tolérance des lymphocytes T.

Autor: Grafiati

Publicado: 18 de mayo de 2024

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Tolérance des lymphocytes T".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Bonnefoy, Nathalie, Daniel Olive y Bernard Vanhove. "Les futures générations d’anticorps modulateurs des points de contrôle de la réponse immunitaire". médecine/sciences 35, n.º 12 (diciembre de 2019): 966–74. http://dx.doi.org/10.1051/medsci/2019193.

Texto completo

Resumen

Les points de contrôle du système immunitaire sont des systèmes moléculaires qui complètent les processus déclenchés par la reconnaissance antigénique en contrôlant l’inhibition ou l’activation des lymphocytes et des cellules myéloïdes, notamment celle des lymphocytes T régulateurs (Treg), permettant ainsi de combiner réponses immunes et maintien de la tolérance au soi. En cancérologie, l’inhibition de points de contrôle inhibiteurs vise à amplifier les réponses immunitaires existantes dirigées contre les tumeurs. Parmi ces points de contrôle inhibiteurs, dont des antagonistes sont en utilisation clinique, se trouvent CTLA-4 (cytolytic T-lymphocyte-associated antigen 4 ou CD152), PD-1 (programmed cell death 1, ou CD279), PD-L1 (programmed cell death-ligand 1, ou CD274), LAG-3 (Lymphocyte-activation gene 3, ou CD223), TIM3 (T-cell immunoglobulin and mucin-domain containing-3), TIGIT (T cell immunoreceptor with Ig and ITIM domains), VISTA (V-domain Ig suppressor of T cell activation), ou B7/H3 (ou CD276). La stimulation de points de contrôle activateurs tels que les molécules de co-activation CD28, CD137 (aussi appelé 4-1BB), OX40 [aussi appelé tumor necrosis factor receptor superfamily, member 4 (TNFRSF4)], GITR (Glucocorticoid-induced tumor necrosis factor receptor family-related protein) ou CD40, est également testée en cancérologie, le plus souvent en combinaison avec un antagoniste de point de contrôle inhibiteur. Dans les maladies auto-immunes et inflammatoires, des antagonistes de points de contrôle activateurs (CD28, CD40) et des agonistes de points de contrôle inhibiteurs (LAG-3) sont également à l’essai. Dans cette revue, nous mettons l’accent sur certains modulateurs de points de contrôle pour lesquels le mécanisme d’action a été particulièrement étudié. Cette description ne pouvant être exhaustive, nous avons regroupé dans le Tableau I l’ensemble des anticorps monoclonaux (AcM) ou protéines recombinantes en usage clinique à notre connaissance, modulant l’action d’un point de contrôle du système immunitaire.

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

Hequet, Olivier, Marc Vocanson, Aurélie Guironnet-paquet, Audrey Nosbaum y Jean-François Nicolas. "Les lymphocytes T CD8+ suppresseurs jouent un rôle majeur dans la tolérance immunitaire induite par la photochimiothérapie extracorporelle". Annales de Dermatologie et de Vénéréologie 143, n.º 12 (diciembre de 2016): S426. http://dx.doi.org/10.1016/j.annder.2016.09.066.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

Ochoa, Juan B. y Valeriya Makarenkova. "T lymphocytes". Critical Care Medicine 33, Suppl (diciembre de 2005): S510—S513. http://dx.doi.org/10.1097/01.ccm.0000186788.71460.53.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

Fabbri, M. "T lymphocytes". International Journal of Biochemistry & Cell Biology 35, n.º 7 (julio de 2003): 1004–8. http://dx.doi.org/10.1016/s1357-2725(03)00037-2.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

Lotteau, V. "La période de tolérance néonatale existe-t-elle ?" médecine/sciences 12, n.º 8-9 (1996): 983. http://dx.doi.org/10.4267/10608/859.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

Robijn, R. J., T. Logtenberg, L. J. J. M. Wiegman, G. P. Van Berge Henegouwen, R. W. Houwen y J. C. Koningsberger. "Intestinal T Lymphocytes". Scandinavian Journal of Gastroenterology 30, sup212 (enero de 1995): 23–33. http://dx.doi.org/10.3109/00365529509090298.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Degos, L. "Les lymphocytes T". médecine/sciences 3, n.º 4 (1987): 229. http://dx.doi.org/10.4267/10608/3665.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

&NA;. "Cytotoxic T lymphocytes". Reactions Weekly &NA;, n.º 1085 (enero de 2006): 12–13. http://dx.doi.org/10.2165/00128415-200610850-00037.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

MARTIN, STEPHEN, ED CANTIN y BARRY T. ROUSE. "Cytotoxic T Lymphocytes." Annals of the New York Academy of Sciences 532, n.º 1 Cytotoxic T C (agosto de 1988): 257–72. http://dx.doi.org/10.1111/j.1749-6632.1988.tb36344.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

Langelot, M., K. Botturi-Cavaillès, D. Lair, F. Wessel, P. Germaud, A. Pipet y A. Magnan. "Lymphocytes T régulateurs". Revue Française d'Allergologie 50, n.º 3 (abril de 2010): 98–101. http://dx.doi.org/10.1016/j.reval.2010.02.015.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Aubin, F. y Ph Saas. "Lymphocytes T régulateurs". Annales de Dermatologie et de Vénéréologie 134, n.º 2 (febrero de 2007): 167–72. http://dx.doi.org/10.1016/s0151-9638(07)91612-9.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Ashton-Rickardt, P. G. y J. T. Opferman. "Memory T lymphocytes". Cellular and Molecular Life Sciences (CMLS) 56, n.º 1-2 (1 de octubre de 1999): 69–77. http://dx.doi.org/10.1007/s000180050007.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

Guichard, Pierre. "L'Andalousie a-t-elle été un paradis de tolérance ?" Les Grands Dossiers des Sciences Humaines N° Hors-série, HS5 (1 de febrero de 2017): 60–61. http://dx.doi.org/10.3917/gdsh.hs5.0060.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

BAGOT, M., M. NIKOLOVA, F. SCHIRM-CHABANETTE, J. WECHSLER, L. BOUMSELL y A. BENSUSSAN. "Crosstalk between Tumor T Lymphocytes and Reactive T Lymphocytes in Cutaneous T Cell Lymphomas". Annals of the New York Academy of Sciences 941, n.º 1 (25 de enero de 2006): 31–38. http://dx.doi.org/10.1111/j.1749-6632.2001.tb03708.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

Hayward, Anthony R. "T-Lymphocytes: An Update". Pediatric Annals 16, n.º 5 (1 de mayo de 1987): 391–94. http://dx.doi.org/10.3928/0090-4481-19870501-06.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Smyth, Mark J., Michael H. Kershaw y Joseph A. Trapani. "XENOSPECIFIC CYTOTOXIC T LYMPHOCYTES". Transplantation 63, n.º 8 (abril de 1997): 1171–78. http://dx.doi.org/10.1097/00007890-199704270-00019.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

Bouladoux, Nicolas, Timothy W. Hand, Shruti Naik y Yasmine Belkaid. "Microbiote et lymphocytes T". médecine/sciences 29, n.º 4 (abril de 2013): 349–52. http://dx.doi.org/10.1051/medsci/2013294005.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

Rouers, Angeline, Raphaël Jeger-Madiot, Arnaud Moris y Stéphanie Graff-Dubois. "Lymphocytes T folliculaireshelperet VIH". médecine/sciences 33, n.º 10 (octubre de 2017): 878–86. http://dx.doi.org/10.1051/medsci/20173310020.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Hamid, Qutayba. "T Lymphocytes in Asthma". Allergy & Clinical Immunology International - Journal of the World Allergy Organization 11, n.º 5 (1999): 0192–94. http://dx.doi.org/10.1027/0838-1925.11.5.192.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

Ward, Stephen G., Kevin Bacon y John Westwick. "Chemokines and T Lymphocytes". Immunity 9, n.º 1 (julio de 1998): 1–11. http://dx.doi.org/10.1016/s1074-7613(00)80583-x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

Nur Çakmak, Fatma, Metin Erol, Pynar Ergül y Altan Yalçyner. "T lymphocytes and vitamins". Journal of Pediatrics 135, n.º 4 (octubre de 1999): 531. http://dx.doi.org/10.1016/s0022-3476(99)70185-x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

Daugherty, Alan y Debra L. Rateri. "T Lymphocytes in Atherosclerosis". Circulation Research 90, n.º 10 (31 de mayo de 2002): 1039–40. http://dx.doi.org/10.1161/01.res.0000021397.28936.f9.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Vallejo, Abbe N., Eduardo Davila, Cornelia M. Weyand y Jörg J. Goronzy. "Biology of T lymphocytes". Rheumatic Disease Clinics of North America 30, n.º 1 (febrero de 2004): 135–57. http://dx.doi.org/10.1016/s0889-857x(03)00114-5.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

Prens, Errol, Reno Debets y Joost Hegmans. "T lymphocytes in psoriasis". Clinics in Dermatology 13, n.º 2 (marzo de 1995): 115–29. http://dx.doi.org/10.1016/0738-081x(95)93818-9.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

Adibzadeh, M., E. Mariani, C. Bartoloni, I. Beckman, G. Ligthart, E. Remarque, S. Shall et al. "Lifespans of T lymphocytes". Mechanisms of Ageing and Development 91, n.º 2 (octubre de 1996): 145–54. http://dx.doi.org/10.1016/0047-6374(96)01783-6.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

Nanno, Masanobu, Yutaka Kanamori, Hisashi Saito, Mariko Kawaguchi-Miyashita, Shin-ichiro Shimada y Hiromichi Ishikawa. "Intestinal Intraepithelial T Lymphocytes". Immunologic Research 18, n.º 1 (agosto de 1998): 41–53. http://dx.doi.org/10.1007/bf02786512.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

Kabelitz, Dieter. "Human γδ T Lymphocytes". International Archives of Allergy and Immunology 102, n.º 1 (1993): 1–9. http://dx.doi.org/10.1159/000236544.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

Globerson, Amiela. "T Lymphocytes and Aging". International Archives of Allergy and Immunology 107, n.º 4 (1995): 491–97. http://dx.doi.org/10.1159/000237091.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

KABELITZ, D., W. R. HERZOG, B. ZANKER y H. WAGNER. "Human Cytotoxic T Lymphocytes." Scandinavian Journal of Immunology 22, n.º 3 (septiembre de 1985): 329–35. http://dx.doi.org/10.1111/j.1365-3083.1985.tb01888.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

BERGSTROM, S. E., D. HAUZENBERGER y K. G. SUNDQVIST. "T Lymphocytes Degrade Fibronectin". Scandinavian Journal of Immunology 33, n.º 4 (abril de 1991): 453–59. http://dx.doi.org/10.1111/j.1365-3083.1991.tb01794.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

31

Guy-Grand, Delphine y Pierre Vassalli. "Gut intraepithelial T lymphocytes". Current Opinion in Immunology 5, n.º 2 (enero de 1993): 247–52. http://dx.doi.org/10.1016/0952-7915(93)90012-h.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

32

Kononova, T. E., O. I. Urazova, V. V. Novitskii y P. A. Zakharova. "CYTOKINE-SECRETORY ACTIVITY OF T-LYMPHOCYTES-HELPERS 17 AND T-LYMPHOCYTES-HELPERS 1 / T-LYMPHOCYTES-HELPERS 17 IN PULMONARY TUBERCULOSIS". Siberian Medical Review, n.º 6 (2017): 57–62. http://dx.doi.org/10.20333/2500136-2017-6-57-62.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

33

Dietl, Johannes, Hans-Peter Horny, Peter Ruck, Klaus Marzusch, Edwin Kaiserling, Henrik Griesser y Dieter Kabelitz. "Intradecidual T lymphocytes lack T-cell receptors". American Journal of Obstetrics and Gynecology 164, n.º 2 (febrero de 1991): 702. http://dx.doi.org/10.1016/s0002-9378(11)80055-4.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

34

Kinoshita, K., T. Amagasaki, S. Ikeda, J. Suzuyama, K. Toriya, K. Nishino, M. Tagawa, M. Ichimaru, S. Kamihira y Y. Yamada. "Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus". Blood 66, n.º 1 (1 de julio de 1985): 120–27. http://dx.doi.org/10.1182/blood.v66.1.120.120.

Texto completo

Resumen

Abstract We report the clinical, hematologic, and immunologic features of 18 preleukemic adult T cell leukemia (pre-ATL) cases with abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus (HTLV/ATLV). The patients were from the Nagasaki district, which is one of the most endemic areas of ATL in Japan. Pre-ATL is a subclinical T cell abnormality differing from ATL. It is characterized by an insidious onset and appearance of abnormal T lymphocytes (10% to 40%) in the peripheral blood without clinical symptoms except for a few cases transiently presenting fever, skin eruptions, and slight lymphadenopathies. Most abnormal T lymphocytes were small and mature with incised or lobulated nuclei and formed E rosettes with sheep RBCs. Virologic and biomolecular analysis revealed that all cases were infected with HTLV, and proviral DNA was integrated in host lymphocytes from 12 of the 14 cases examined. Furthermore, the lymphocyte populations, including abnormal T lymphocytes, were monoclonal with respect to the site of the provirus integration. Abnormal T lymphocytosis persisted from one to more than seven years in six cases, three of which developed ATL after a one- to five-year pre-ATL stage, whereas abnormal T lymphocytes spontaneously decreased in the other seven patients. However, HTLV-infected monoclonal lymphocytes were detected in four cases examined, even after most of the abnormal T lymphocytes had disappeared. Moreover, the same clonally provirus- integrated lymphocytes persisted in two of four cases not only during the course of abnormal lymphocytosis, but also in the subsequent almost- normal blood. These results indicate that the majority of the cases were in a pre-ATL state with a potential to develop ATL.

Los estilos APA, Harvard, Vancouver, ISO, etc.

35

Kinoshita, K., T. Amagasaki, S. Ikeda, J. Suzuyama, K. Toriya, K. Nishino, M. Tagawa, M. Ichimaru, S. Kamihira y Y. Yamada. "Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus". Blood 66, n.º 1 (1 de julio de 1985): 120–27. http://dx.doi.org/10.1182/blood.v66.1.120.bloodjournal661120.

Texto completo

Resumen

We report the clinical, hematologic, and immunologic features of 18 preleukemic adult T cell leukemia (pre-ATL) cases with abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus (HTLV/ATLV). The patients were from the Nagasaki district, which is one of the most endemic areas of ATL in Japan. Pre-ATL is a subclinical T cell abnormality differing from ATL. It is characterized by an insidious onset and appearance of abnormal T lymphocytes (10% to 40%) in the peripheral blood without clinical symptoms except for a few cases transiently presenting fever, skin eruptions, and slight lymphadenopathies. Most abnormal T lymphocytes were small and mature with incised or lobulated nuclei and formed E rosettes with sheep RBCs. Virologic and biomolecular analysis revealed that all cases were infected with HTLV, and proviral DNA was integrated in host lymphocytes from 12 of the 14 cases examined. Furthermore, the lymphocyte populations, including abnormal T lymphocytes, were monoclonal with respect to the site of the provirus integration. Abnormal T lymphocytosis persisted from one to more than seven years in six cases, three of which developed ATL after a one- to five-year pre-ATL stage, whereas abnormal T lymphocytes spontaneously decreased in the other seven patients. However, HTLV-infected monoclonal lymphocytes were detected in four cases examined, even after most of the abnormal T lymphocytes had disappeared. Moreover, the same clonally provirus- integrated lymphocytes persisted in two of four cases not only during the course of abnormal lymphocytosis, but also in the subsequent almost- normal blood. These results indicate that the majority of the cases were in a pre-ATL state with a potential to develop ATL.

Los estilos APA, Harvard, Vancouver, ISO, etc.

36

Vianna-Jorge, Rosane y Guilherme Suarez-Kurtz. "Potassium Channels in T Lymphocytes". BioDrugs 18, n.º 5 (2004): 329–41. http://dx.doi.org/10.2165/00063030-200418050-00005.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

37

Guse, Andreas H. "Ca2+ Signaling in T-Lymphocytes". Critical Reviews™ in Immunology 18, n.º 5 (1998): 419–48. http://dx.doi.org/10.1615/critrevimmunol.v18.i5.20.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

38

Jandrić-Kočić, Marijana. "Recirculation of naive T lymphocytes". Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma 27, n.º 86 (2022): 25–48. http://dx.doi.org/10.5937/mgiszm2286025j.

Texto completo

Resumen

After development in the thymus, naive T lymphocytes come into circulation and continuously recirculate between the blood and peripheral lymphoid organs for activation and transformation into effector cells. The movement of naive T lymphocytes represents an ordered sequence controlled by the expression of specific of specific proteins (selectin, integrin and chemokine) that includes the recruitment of circulating lymphocytes on the luminal surface of the blood vessel, transendothelial transition and migration within the extravascular compartment of peripheral lymphoid organs. The question of the movement of naive T lymphocytes in and out of non-lymphoid organs in physiological conditions has not been fully resolved. There is an opinion that naive T lymphocytes under physiological conditions routinely access almost all non-lymphoid organs for the purpose of immunosurveillance and/or tolerance induction. Non-lymphoid organs burdened by chronic inflammation and tumor processes may possess a significant number of naive T lymphocytes. Organized lymphoid tissue causally contributes to the persistence of certain autoimmune diseases. Recruitment in tumor tissue and subsequent antitumor immune response correspond with a positive prognosis.

Los estilos APA, Harvard, Vancouver, ISO, etc.

39

Bockenstedt, Linda K., Mark A. Goldsmith, Gary A. Koretzky y Arthur Weiss. "The Activation of T Lymphocytes". Rheumatic Disease Clinics of North America 13, n.º 3 (diciembre de 1987): 411–30. http://dx.doi.org/10.1016/s0889-857x(21)00926-1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

40

Krensky, Alan M. y Carol Clayberger. "MHC-Unrestricted cytolytic T lymphocytes". Survey of Immunologic Research 4, n.º 4 (diciembre de 1985): 297–302. http://dx.doi.org/10.1007/bf02918737.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

41

Rowe-Pirra, William. "Comment s’épuisent les lymphocytes T". Pour la Science N° 530 – décembre, n.º 12 (29 de noviembre de 2021): 12. http://dx.doi.org/10.3917/pls.530.0012.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

42

Arokiaraj, M. C. y E. Menesson. "Rose treatment on T lymphocytes". Atherosclerosis 331 (agosto de 2021): e81. http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.238.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

43

Kay, A. B. y S. R. Durham. "T-lymphocytes, allergy and asthma". Clinical Experimental Allergy 21, s1 (mayo de 1991): 17–21. http://dx.doi.org/10.1111/j.1365-2222.1991.tb01700.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

44

Sheibak, V. M. y A. Y. Pauliukavets. "Biochemical heterogeneity of T-lymphocytes". Vestnik of Vitebsk State Medical University 17, n.º 6 (29 de noviembre de 2018): 7–17. http://dx.doi.org/10.22263/2312-4156.2018.6.7.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

45

Martinez, Olivia M. "Immunobiology of CD30+ T Lymphocytes". Graft 4, n.º 3 (abril de 2001): 180–87. http://dx.doi.org/10.1177/152216280100400302.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

46

Dotti, Gianpietro. "T Lymphocytes Are Not Immune". Molecular Therapy 21, n.º 6 (junio de 2013): 1114–15. http://dx.doi.org/10.1038/mt.2013.102.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

47

VON BOEHMER, HARALD, HORST BLUETHMANN, UWE STAERZ, MICHAEL STEINMETZ y PAWEL KISIELOW. "Developmental Biology of T Lymphocytes." Annals of the New York Academy of Sciences 546, n.º 1 Molecular Bas (diciembre de 1988): 104–8. http://dx.doi.org/10.1111/j.1749-6632.1988.tb21624.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

48

van Oosterhout, A. J. M. "Regulatory T-lymphocytes in asthma". European Respiratory Journal 26, n.º 5 (1 de noviembre de 2005): 918–32. http://dx.doi.org/10.1183/09031936.05.00011205.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

49

BERETTA, LAURA. "TRANSLATIONAL CONTROL IN T LYMPHOCYTES". International Reviews of Immunology 23, n.º 3-4 (enero de 2004): 347–63. http://dx.doi.org/10.1080/08830180490452549.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

50

Vié, H. y B. Clémenceau. "Transfert adoptif de lymphocytes T". Transfusion Clinique et Biologique 24, n.º 3 (septiembre de 2017): 256–62. http://dx.doi.org/10.1016/j.tracli.2017.05.018.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!